SCHULER JACK W — SEC Form 4 filings
SEC reporting owner CIK 1021412. 25 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-01-25 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 19 legs across 15 filings — 10,365,716 shares, $8,138,699 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 236,000 shares, $321,200 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: purchase of 3,488,372 shares @ $0.43 ($1,500,000) in BIODESIX INC, filed 2025-09-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIODESIX INC (BDSX) | 10% owner | 13 | 15 legs · 8,997,347 sh · $7,538,700 | — | 5 |
| Aspira Women's Health Inc. (AWHL) | 10% owner | 5 | 4 legs · 1,368,369 sh · $600,000 | — | 5 |
| Accelerate Diagnostics, Inc (AXDX) | Director, 10% owner | 6 | — | 1 leg · 200,000 sh · $314,000 | 9 |
| YIELD10 BIOSCIENCE, INC. (YTEN) | 10% owner | 1 | — | 1 leg · 36,000 sh · $7,200 | — |
Form 4 filings — SCHULER JACK W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | BIODESIX INC (BDSX) | Purchase (P): 15,000 @ $24.47 | EDGAR |
| 2026-08-12 | 4 | BIODESIX INC (BDSX) | Purchase (P): 13,900 @ $24.25 · Purchase (P): 13,700 @ $24.01 | EDGAR |
| 2026-06-09 | 4 | Aspira Women's Health Inc. (AWHL) | Purchase (P): 222,222 @ $0.45 · Purchase (P): 300,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | BIODESIX INC (BDSX) | Purchase (P): 80,000 @ $11.81 · Purchase (P): 20,000 @ $11.80 | EDGAR |
| 2026-01-26 | 4 | BIODESIX INC (BDSX) | Purchase (P): 82,465 @ $10.96 | EDGAR |
| 2025-09-23 | 4 | BIODESIX INC (BDSX) | Purchase (P): 142,045 @ $7.04 | EDGAR |
| 2025-09-19 | 4 | BIODESIX INC (BDSX) | Purchase (P): 15,317 @ $6.04 · Purchase (P): 3,056 @ $6.17 | EDGAR |
| 2025-09-19 | 4 | Aspira Women's Health Inc. (AWHL) | Purchase (P): 1,111,111 @ $0.45 · Purchase (P): 833,333 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | BIODESIX INC (BDSX) | Purchase (P): 3,488,372 @ $0.43 | EDGAR |
| 2025-05-20 | 4 | BIODESIX INC (BDSX) | Purchase (P): 4,000,000 @ $0.27 · Purchase (P): 723,239 @ $0.34 | EDGAR |
| 2025-03-10 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P) @ $200,000 | EDGAR |
| 2024-12-03 | 4 | Accelerate Diagnostics, Inc (AXDX) | Sale (S): 200,000 @ $1.57 | EDGAR |
| 2024-11-22 | 4 | BIODESIX INC (BDSX) | Purchase (P): 100,000 @ $1.23 | EDGAR |
| 2024-11-21 | 4 | BIODESIX INC (BDSX) | Purchase (P): 200,000 @ $1.17 | EDGAR |
| 2024-11-06 | 4 | BIODESIX INC (BDSX) | Purchase (P): 100,253 @ $1.36 | EDGAR |
| 2024-07-11 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P): 6,536 · Purchase (P): 6,536 (derivative) | EDGAR |
| 2024-07-01 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 4,737 @ $0 · Option exercise (M): 4,737 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P): 28,500 · Purchase (P): 28,500 (derivative) | EDGAR |
| 2024-05-30 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 7,894 @ $0 · Option exercise (M): 7,894 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BIODESIX INC (BDSX) | Option exercise (M): 86,960 · Grant/award (A): 46,686 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0 · Option exercise (M): 2,174 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 1,560,694 · Grant/award (A): 1,560,694 (derivative) | EDGAR |
| 2024-05-21 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 36,000 @ $0.20 | EDGAR |
| 2024-04-09 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 2,174 (derivative) @ $46 | EDGAR |
| 2024-01-25 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 1,156,069 · Grant/award (A): 1,156,069 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1021412 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →